Logout Login Cart iconShop
Contact Sales

Search

Filters

Content Type

Products

Clear Filters

Search Results for "【Order On Telegram: @Chem2Door】Where To Buy Lunesta In San Diego,.7093"

Looking for quality documents?
external link icon
Repligen to Present at Stifel Healthcare Conference 2014
WALTHAM, Mass., Nov. 12, 2014 (GLOBE NEWSWIRE) - Repligen Corporation (Nasdaq:RGEN) today announced that Walter C. Herlihy, Ph.D., President and Chief Executive Officer, will present at the Stifel Healthcare Conference 2014 on Wednesday, November 19 at 10:55 a.m. EST. The conference will be held at the New York Palace Hotel in New York City. The Repligen presentation will be webcast live and will be accessible through the Investor Events section of Company's website. The webcast and slide presentation will also be archived on the Company's website for a period of time following the event. About Repligen Corporation Repligen Corporation (Nasdaq:RGEN) is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. We are the leading manufacturer of Protein A affinity ligands, a critical
external link icon
Repligen to Report Third Quarter 2014 Financial Results
WALTHAM, Mass., Oct. 23, 2014 (GLOBE NEWSWIRE) - Repligen Corporation (Nasdaq:RGEN) today announced that it will report third quarter 2014 financial results on Thursday, November 6, 2014. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. EST to discuss business updates and financial results for the reporting period ended September 30, 2014. Repligen's third quarter conference call will be accessible by dialing toll-free (844) 835-7432 for domestic callers or (404) 537-3372 for international callers. Dial-in participants must provide the passcode 24804552. In addition, a webcast will be accessible via the Investor Relations section of the Company's website. Both the conference call and webcast will be archived for a period of time following the live event. The replay dial-in numbers are (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. Replay listeners must provide the passcode 24804552. About
external link icon
Repligen to Report Second Quarter 2014 Financial Results
WALTHAM, Mass., July 28, 2014 (GLOBE NEWSWIRE) - Repligen Corporation (Nasdaq:RGEN) today announced that it will report second quarter 2014 financial results on Monday, August 11, 2014. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. EDT to discuss business updates and financial results for the reporting period ended June 30, 2014. Repligen's second quarter conference call will be accessible by dialing toll-free (844) 835-7432 for domestic callers or (404) 537-3372 for international callers. Dial-in participants must provide the passcode 77432919. In addition, a webcast will be accessible via the Investor Relations section of Repligen's website www.repligen.com ; see Events & Presentations. Both the conference call and webcast will be archived for a period of time following the live event. The replay dial-in numbers are (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. Replay listeners must
external link icon
Repligen to Report First Quarter 2014 Financial Results
WALTHAM, Mass., April 25, 2014 (GLOBE NEWSWIRE) - Repligen Corporation (Nasdaq:RGEN) today announced that it will report first quarter 2014 financial results on Thursday, May 8, 2014. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. EDT to discuss business updates and financial results for the reporting period ended March 31, 2014. Repligen's first quarter conference call will be accessible by dialing toll-free (844) 835-7432 for domestic callers or (404) 537-3372 for international callers. Dial-in participants must provide the passcode 35070834. In addition, a webcast will be accessible via the Investor Relations section of Repligen's website www.repligen.com ; see Events & Presentations. Both the conference call and webcast will be archived for a period of time following the live event. The replay dial-in numbers are (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. Replay listeners must
external link icon
Repligen to Report Third Quarter 2013 Financial Results
WALTHAM, Mass., Oct. 24, 2013 (GLOBE NEWSWIRE) - Repligen Corporation (Nasdaq:RGEN) today announced that it will report third quarter 2013 financial results on Thursday, November 7, 2013. The Company will issue a press release before the market opens, and will host a conference call at 9:00 a.m. EST to discuss business updates and financial results for the reporting period ended September 30, 2013. Repligen's third quarter conference call will be accessible by dialing (877) 415-3180 for domestic callers or (857) 244-7323 for international callers. Dial-in participants must provide the passcode 31006698. Alternatively, an audio webcast will be accessible via the Investor section of Repligen's website www.repligen.com . Both the conference call and webcast will be archived for a period of time following the live event. The replay dial-in numbers are (888) 286-8010 for domestic callers and (617) 801-6888 for international callers. Replay listeners must provide the passcode 30270739.
external link icon
Repligen to Report Second Quarter 2013 Financial Results
WALTHAM, Mass., July 18, 2013 (GLOBE NEWSWIRE) - Repligen Corporation (Nasdaq:RGEN) today announced that it will report second quarter 2013 financial results on Thursday, August 1, 2013. The Company will issue a press release before the market opens, and will host a conference call at 9:00 a.m. EDT to discuss financial results for the reporting period ended June 30, 2013. Repligen's second quarter conference call will be accessible by dialing (877) 280-4960 for domestic callers or (857) 244-7317 for international callers. Dial-in participants must provide the passcode 52303386. Alternatively, an audio webcast will be accessible via the Investor section of Repligen's website www.repligen.com . Both the conference call and webcast will be archived for a period of time following the live event. The replay dial-in numbers are (888) 286-8010 for domestic callers and (617) 801-6888 for international callers. Replay listeners must provide the passcode 22671187. About Repligen Corporation
external link icon
Repligen to Report First Quarter 2013 Financial Results
WALTHAM, Mass., April 23, 2013 (GLOBE NEWSWIRE) - Repligen Corporation (Nasdaq:RGEN) today announced that it will report financial results for the first quarter 2013 on Thursday, May 2, 2013. The Company will issue a press release prior to market opening and will host a webcast and conference call with management at 9:00 a.m. EDT to discuss financial results for the reporting period ended March 31, 2013 and provide a general business update. Repligen's first quarter conference call will be accessible by dialing (866) 804-6922 for domestic callers or (857) 350-1668 for international callers. Dial-in participants must provide the passcode 92537192. Alternatively, an audio webcast will be accessible via the Investor section of Repligen's website www.repligen.com . Both the conference call and webcast will be archived for a period of time following the live event. The replay dial-in numbers are (888) 286-8010 for domestic callers and (617) 801-6888 for international callers. Replay
external link icon
Repligen CEO to Present at Upcoming Investor Conferences
- Stephens Fall Investment Conference & Piper Jaffray Healthcare Conference - Repligen Corporation (NASDAQ:RGEN) today announced that Walter C. Herlihy, Ph.D., President and Chief Executive Officer, will be presenting at two investor conferences in November. Dr. Herlihy will first participate in the Stephens Fall Investment Conference on November 14, and will later present at the Piper Jaffray 24 th Annual Healthcare Conference on November 27. Both conferences will take place at The New York Palace Hotel. At each, Dr. Herlihy will provide a corporate update and address questions from the audience. Repligen’s presentation at the Piper Jaffray Annual Healthcare Conference will be webcast and made available live through the Investors section of Company’s website at www.repligen.com . This presentation is currently scheduled to begin on Tuesday, November 27 at 8:50 a.m. EST. To access the live webcast, please log on approximately 15 minutes prior to the scheduled start time. The
external link icon
Repligen to Present at BIO CEO & Investor Conference
corporate icon
PATsmart™ SoloVPE® PLUS System
UV-Vis Concentration Measurement for GMP and Non-GMP Testing The new PATsmart™ SoloVPE® PLUS System features patented variable pathlength technology (VPT), providing precise concentration measurements with no need for costly dilutions. This reliable solution delivers fast, accurate results with system-to-system, operator-to-operator, and site-to-site consistency, ensuring high-quality performance across various bioprocessing applications.
Close modal

A new look. A better way to explore Repligen.

We’ve redesigned Repligen.com to help you find the right solutions faster, with greater clarity and less effort.

Find what you need faster
Get to the right information with quicker site speed

Explore the site with ease
Navigate easily with an intuitive, simple site structure

Access product details instantly
Find products and resources faster, in fewer clicks

Get support when you need it
Connect with our team when you need support